Choose Language
Select a language for news translation.
The mFlusiva vaccine will soon be available for adults aged 50 and over. After initially refusing to even review it, the US Food and Drug Administration (FDA)…
The Food and Drug Administration on Wednesday approved the U.S.’s first flu shot that uses mRNA technology: mFlusiva, from drugmaker Moderna.
The Food and Drug Administration is expected to decide whether to approve the first mRNA flu vaccine.
The U.S. Army's stockpile of long-range missiles is nearly depleted due to ongoing military operations in Iran, raising concerns about military readiness. Simu…
The FDA will soon decide whether to approve the first flu vaccine that uses the same mRNA technology as COVID-19 shots. Health Secretary Robert F. Kennedy Jr. …
Moderna will soon learn the regulatory fate of its mRNA-based flu shot. Maddie Meyer/Getty Images hide caption For the latest stories on the science of health…
Moderna Inc (Symbol: MRNA) options are showing a volume of 94,398 contracts thus far today. That number of contracts represents approximately 9.4 million under…
(RTTNews) - Moderna, Inc (MRNA) released Loss for second quarter of -$782 million The company's earnings totaled -$782 million, or -$1.97 per share. This comp…
Moderna's stock has risen nearly 90% in 2026, fueled by optimism over its mRNA-1010 flu vaccine, which received FDA advisory support. However, the company face…
